Teemu Kalle Eemeli Rönkkö

Teemu Kalle Eemeli Rönkkö is a Research Fellow at the Department of Drug Design and Pharmacology within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research integrates computational methods with pharmacological applications, focusing on drug discovery and disease mechanism analysis.

His academic foundation includes:

• MSc in Bioinformatics from the University of Copenhagen (2019-2021)
• BSc in Cognitive Science from Aarhus University (2016-2019)

Rönkkö specializes in applying artificial intelligence to bioinformatics challenges, particularly in protein structure prediction and computational drug design. His work leverages machine learning for GPCR-targeted peptide binding studies and proteomic analysis of diabetic complications. Current projects involve deep learning benchmarking for pharmacological targets and clinical trial data interpretation.

His publication trend reveals a dual focus: computational pharmacology (2025) and clinical-translational research (2024). The 2025 article establishes methodological rigor in AI-driven drug discovery, while the 2024 clinical trial study bridges computational biology with nephrology, demonstrating cross-disciplinary impact in both basic and applied medical research.

Rönkkö collaborates internationally within pharmaceutical informatics, utilizing high-performance computing resources at the University of Copenhagen to advance structure-based drug design and biomarker identification for complex diseases.